Masarykova univerzita

Výpis publikací

česky | in English

Filtrování publikací

    2021

  1. EITZINGER, A., Jan OTEVŘEL, V. HAIDER, A. MACCHIA, A. MASSA, K. FAUST, B. SPINGLER, A. BERKESSEL a M. WASER. Enantioselective Bifunctional Ammonium Salt-Catalyzed Syntheses of 3-CF3S-, 3-RS-, and 3-F-Substituted Isoindolinones. ADVANCED SYNTHESIS & CATALYSIS. WEINHEIM: WILEY-V C H VERLAG GMBH, 2021, roč. 363, č. 363, s. 1955-1963. ISSN 1615-4150. doi:10.1002/adsc.202100029.
  2. 2020

  3. STROUHALOVA, D., D. MACEJOVA, B. MOSNA, Pavel BOBÁĽ, Jan OTEVŘEL, M. LASTOVICKOVA, J. BRTKO a J. BOBALOVA. Down-regulation of vimentin by triorganotin isothiocyanates-nuclear retinoid X receptor agonists: A proteomic approach. Toxicology Letters. CLARE: Elsevier, 2020, roč. 318, č. 318, s. 22-29. ISSN 0378-4274. doi:10.1016/j.toxlet.2019.10.004.
  4. OTEVŘEL, Jan, David ŠVESTKA a Pavel BOBÁĽ. One-pot method for the synthesis of 1-aryl-2-aminoalkanol derivatives from the corresponding amides or nitriles. RSC Advances. Cambridge: Royal Society of Chemistry, 2020, roč. 10, č. 42, s. 25029-25045. ISSN 2046-2069. doi:10.1039/d0ra04359a.
  5. 2019

  6. BOBÁĽ, Pavel a Jan OTEVŘEL. Bianthryl-based organocatalysts for the asymmetric Henry reaction of fluoroketones. Organic & Biomolecular Chemistry. 2019. doi:10.1039/c9ob00884e.
  7. BOBÁĽ, Pavel a Jan OTEVŘEL. Genotoxic Effects of Tributyltin and Triphenyltin Isothiocyanates, Cognate RXR Ligands: Comparison in Human Breast Carcinoma MCF 7 and MDA-MB-231 Cells. International Journal of Molecular Sciences. 2019. doi:10.3390/ijms20051198.
  8. BOBÁĽ, Pavel a Jan OTEVŘEL. Triorganotin derivatives: time-dependent expression of Vimentin, Annexin A5 and selected nuclear receptors mRNA in MDA-MB-231 breast cancer cells. 2019.
  9. OTEVŘEL, Jan a Pavel BOBÁĽ. Triorganotin Isothiocyanates Affect Migration and Immune Check-point Receptors in Human Triple-negative Breast Carcinoma MDA-MB-231 Cells. ANTICANCER RESEARCH. 2019. doi:10.21873/anticanres.13670.
  10. 2018

  11. OTEVŘEL, Jan a Pavel BOBÁĽ. Effects of selected triorganotin compounds on transcriptional activity of vitamin D-3 receptor and peroxisome proliferator-activated receptor gamma? GENERAL PHYSIOLOGY AND BIOPHYSICS. 2018. doi:10.4149/gpb_2018021.
  12. OTEVŘEL, Jan a Pavel BOBÁĽ. Triorganotin derivatives induce cell death effects on L1210 leukemia cells at submicromolar concentrations independently of P-glycoprotein expression. MOLECULES. 2018. doi:10.3390/molecules23051053.
  13. 2017

  14. VETTORAZZI, M, E ANGELINA, S LIMA, Tomáš GONĚC, Jan OTEVŘEL, Pavlína MARVANOVÁ, Tereza PADRTOVÁ, Petr MOKRÝ, Pavel BOBÁĽ, LM ACOSTA, A PALMA, J COBO, Janette BOBÁĽOVÁ, Jozef CSÖLLEI, Ivan MALÍK, S ALVAREZ, S SPIEGEL, J JAMPILEK a RD ENRIZ. An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors. European Journal of Medicinal Chemistry. PARIS: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2017, roč. 139, s. 461-481. ISSN 0223-5234. doi:10.1016/j.ejmech.2017.08.017.
  15. BOBÁĽ, Pavel a Jan OTEVŘEL. Analysis of proteomic changes in MDA-MB-231 cells induced by selected triorganotin compounds, biologically active ligands of nuclear retinoid X receptors? 2017. doi:10.1016/j.toxlet.2017.08.066.
  16. BOBÁĽ, Pavel a Jan OTEVŘEL. Biphenyl-Based Bis(thiourea) Organocatalyst for Asymmetric and syn-Selective Henry Reaction. Synthesis-Stuttgart. 2017. doi:10.1055/s-0036-1588594.
  17. BOBÁĽ, Pavel a Jan OTEVŘEL. Diamine-Tethered Bis(thiourea) Organocatalyst for Asymmetric Henry Reaction. Journal of Organic Chemistry. 2017. doi:10.1021/acs.joc.7b00079.
  18. 2015

  19. BOBÁĽ, Pavel, Jan OTEVŘEL, Z. POBORILOVA, Veronika VAVERKOVÁ, Jozef CSÖLLEI a Petr BABULA. Application of BY-2 cell model in evaluating an effect of newly prepared potential calcium channel blockers. PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES. KARACHI: UNIV KARACHI, 2015, roč. 28, č. 4, s. 1281-1293. ISSN 1011-601X.
Zobrazit podrobně
Zobrazeno: 3. 8. 2021 17:20